Carlos Trabanco, MD

Original Research

Effectiveness of Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial for the Treatment of Pressure Injuries

05/31/2022

Kerry T. Thibodeaux , MD;

Michael J. Menack ;

Michael Leon Sabolinski , MD;

Carlos Trabanco , MD;

The authors describe the effects of PCMP in the subgroup of patients with pressure injuries from the RESPOND registry.

The authors describe the effects...

05/31/2022

Wounds

Effectiveness of a native Type I Collagen matrix plus polyhexamethylene biguanide (PHMB) antimicrobial in the treatment of pressure injuries in a real-world setting

Objective: To analyze the subgroup of Pressure Injuries (PRIs) in the 28 site, prospective, non-interventional, PCMP registry (RESPOND)(a) that evaluated the real-world effectiveness of P...

Kerry T. Thibodeaux , MD;

Michael J. Menack ;

Michael Leon Sabolinski , MD;

Carlos Trabanco , MD;

08/19/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Carlos Trabanco, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products